Drugs / IG001119
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07618247 | Jun 2026 → Apr 2027 expected | — | Iongen Therapeutics Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IG001119 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07618247 ↗ |
| Route | Oral | “Tablets for oral administration.” NCT07618247 ↗ |